Group One Trading
KNSA icon

Group One Trading’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Group One Trading’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,100
Closed -$24.4K – 8303
2025
Q1 		$24.4K Buy
1,100
+1,000
+1,000% +$20.6K ﹤0.01% 5684
2024
Q4 		$1.98K Buy
+100
New +$2.28K ﹤0.01% 6740
2024
Q3 		– Sell
-100
Closed -$1.87K – 6997
2024
Q2 		$1.87K Buy
+100
New +$1.87K ﹤0.01% 6240
2024
Q1 		– Sell
-8,000
Closed -$140K – 7509
2023
Q4 		$140K Sell
8,000
-25,200
-76% -$414K ﹤0.01% 4181
2023
Q3 		$577K Buy
33,200
+22,100
+199% +$372K ﹤0.01% 2770
2023
Q2 		$156K Buy
+11,100
New +$149K ﹤0.01% 4188
2022
Q3 		– Sell
-9,300
Closed -$90K – 7882
2022
Q2 		$90K Buy
9,300
+2,000
+27% +$18.7K ﹤0.01% 5078
2022
Q1 		$73K Sell
7,300
-5,000
-41% -$53K ﹤0.01% 5792
2021
Q4 		$145K Sell
12,300
-34,800
-74% -$428K ﹤0.01% 5400
2021
Q3 		$536K Buy
47,100
+6,800
+17% +$88.6K ﹤0.01% 4122
2021
Q2 		$561K Buy
40,300
+34,500
+595% +$524K ﹤0.01% 4093
2021
Q1 		$107K Buy
+5,800
New +$119K ﹤0.01% 5597

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Group One Trading's KNSA Position: Q1 2026 in Review

Group One Trading sold out of Kiniksa Pharmaceuticals (KNSA) in Q1 2026, closing a stake of 200 shares — an estimated $8.86K sold.

Group One Trading first reported a position in KNSA in Q1 2021 and held it in 12 quarters. The position peaked at $312K in Q3 2021. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Group One Trading reported no remaining Kiniksa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 200 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $8.86K.
  • Group One Trading first reported a position in Kiniksa Pharmaceuticals in Q1 2021 and held it in 12 quarters.
  • Group One Trading's Kiniksa Pharmaceuticals position peaked at $312K in Q3 2021.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.